DANA LINGEL: Open Payments
NPI 1740905488 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,317 in 198 payments from 23 companies in 2025. Trend: 2023 $4,333 · 2024 $5,319 · 2025 $4,317
Food & beverage: $4,269Education: $48
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 30 | $590 |
| ABBVIE INC. | 30 | $479 |
| UCB, Inc. | 18 | $442 |
| GENZYME CORPORATION | 12 | $409 |
| Incyte Corporation | 9 | $324 |
| LEO Pharma Inc. | 17 | $288 |
| Regeneron Healthcare Solutions, Inc. | 7 | $281 |
| Novartis Pharmaceuticals Corporation | 15 | $255 |
| Arcutis Biotherapeutics, Inc. | 8 | $240 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 13 | $236 |
Products named: DUPIXENT, Bimzelx, NEMLUVIO, SKYRIZI, Zoryve, TREMFYA, ADBRY, OPZELURA.
Industry payments across IN — which companies pay providers there.
